HighTower Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
HighTower Advisors's CNMD Position: Q3 2026 in Review
HighTower Advisors opened a new position in CONMED (CNMD) in Q3 2026: 8,397 shares worth $388K. The stake represents ﹤0.01% of the portfolio and ranks #2964 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in CNMD as recently as Q3 2025.
HighTower Advisors first reported a position in CNMD in Q2 2018 and has held it in 22 quarters since. The position peaked at $3.29M in Q4 2023. 270 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.
- HighTower Advisors held 8,397 shares of CONMED worth $388K as of Q3 2026.
- CONMED was a new HighTower Advisors position in Q3 2026.
- CONMED made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2964 holding.
- HighTower Advisors first reported a position in CONMED in Q2 2018 and has held it in 22 quarters since.
- HighTower Advisors's CONMED position peaked at $3.29M in Q4 2023.
- 270 funds tracked by Wall St. Rank held CONMED as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.